General Fluidics develops an in vitro diagnostic tool for performing a growing array of blood and urine tests.
General Fluidics has raised $18.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2024.
General Fluidics is headquartered in Waltham, United States.
General Fluidics develops an in vitro diagnostic tool for performing a growing array of blood and urine tests.
General Fluidics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"General Fluidics — Funding & Investors." VCBacked, July 31, 2024, https://www.vcbacked.co/company/general-fluidics. Accessed August 14, 2026.
VCBacked. (2024). General Fluidics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/general-fluidics
{{cite web |title=General Fluidics — Funding & Investors |url=https://www.vcbacked.co/company/general-fluidics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated